Avodart
Product Images NDC 54868-5114

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Avodart (NDC 54868-5114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Dutasteride Structural Formula (12b15be8 C3de 4732 B9a7 1c06c5e6c385 01)

Dutasteride Structural Formula (12b15be8 C3de 4732 B9a7 1c06c5e6c385 01)
FDA Label Image

Figure 1. Aua-si Score* Change From Baseline (randomized, Double-blind, Placebo-controlled Studies Pooled) (12b15be8 C3de 4732 B9a7 1c06c5e6c385 02)

Figure 1. Aua-si Score* Change From Baseline (randomized, Double-blind, Placebo-controlled Studies Pooled) (12b15be8 C3de 4732 B9a7 1c06c5e6c385 02)
FDA Label Image

Figure 2. Percent Of Subjects Developing Acute Urinary Retention Over A 24-month Period (randomized, Double-blind, Placebo-controlled Studies Pooled) (12b15be8 C3de 4732 B9a7 1c06c5e6c385 03)

Figure 2. Percent Of Subjects Developing Acute Urinary Retention Over A 24-month Period (randomized, Double-blind, Placebo-controlled Studies Pooled) (12b15be8 C3de 4732 B9a7 1c06c5e6c385 03)
FDA Label Image

Figure 3. Percent Of Subjects Having Surgery For Benign Prostatic Hyperplasia Over A 24-month Period (randomized, Double-blind, Placebo-controlled Studies Pooled) (12b15be8 C3de 4732 B9a7 1c06c5e6c385 04)

Figure 3. Percent Of Subjects Having Surgery For Benign Prostatic Hyperplasia Over A 24-month Period (randomized, Double-blind, Placebo-controlled Studies Pooled) (12b15be8 C3de 4732 B9a7 1c06c5e6c385 04)
FDA Label Image

Figure 4. Prostate Volume Percent Change From Baseline (randomized, Double-blind, Placebo-controlled Studies Pooled) (12b15be8 C3de 4732 B9a7 1c06c5e6c385 05)

Figure 4. Prostate Volume Percent Change From Baseline (randomized, Double-blind, Placebo-controlled Studies Pooled) (12b15be8 C3de 4732 B9a7 1c06c5e6c385 05)
FDA Label Image

Figure 5. Qmax Change From Baseline (randomized, Double-blind, Placebo-controlled Studies Pooled) (12b15be8 C3de 4732 B9a7 1c06c5e6c385 06)

Figure 5. Qmax Change From Baseline (randomized, Double-blind, Placebo-controlled Studies Pooled) (12b15be8 C3de 4732 B9a7 1c06c5e6c385 06)
FDA Label Image

Figure 6. (12b15be8 C3de 4732 B9a7 1c06c5e6c385 07)

Figure 6. (12b15be8 C3de 4732 B9a7 1c06c5e6c385 07)
FDA Label Image

Figure 7. Q-max Change Ffrom Baseline Over A 24-month Period (randomized, Double-blind, Parallel Group Study [combat Study]) (12b15be8 C3de 4732 B9a7 1c06c5e6c385 08)

Figure 7. Q-max Change Ffrom Baseline Over A 24-month Period (randomized, Double-blind, Parallel Group Study [combat Study]) (12b15be8 C3de 4732 B9a7 1c06c5e6c385 08)
FDA Label Image

Avodart 0.5 mg Capsules Label (5114)

Avodart 0.5 mg Capsules Label (5114)
This is a medication called Avodart that comes in a package of 6,516. The distributor is Physicians Total Care and the product has an NDC number of 54868-5114-8. There is also a code which may be a lot or serial number (51140366000) but its specific meaning is not clear.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.